Mirum Pharmaceuticals, Inc.
MIRM
$71.97
$0.160.22%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.86M | -14.68M | -23.79M | -14.24M | -24.64M |
| Total Depreciation and Amortization | 6.06M | 6.05M | 7.41M | 6.06M | 5.85M |
| Total Amortization of Deferred Charges | 427.00K | 433.00K | 416.00K | 424.00K | 407.00K |
| Total Other Non-Cash Items | 17.97M | 17.53M | 12.58M | 8.41M | 13.01M |
| Change in Net Operating Assets | -6.56M | -11.30M | -1.68M | 3.33M | 1.56M |
| Cash from Operations | 12.04M | -1.96M | -5.07M | 3.98M | -3.80M |
| Capital Expenditure | -126.00K | -41.00K | -20.00K | -181.00K | -779.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6.47M | -16.09M | 661.00K | -17.86M | -71.94M |
| Cash from Investing | -6.60M | -16.13M | 641.00K | -18.04M | -72.72M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 8.69M | 6.36M | 5.34M | 3.86M | 7.29M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 8.69M | 6.36M | 5.34M | 3.86M | 7.29M |
| Foreign Exchange rate Adjustments | 2.23M | 1.06M | -1.38M | 88.00K | -119.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 16.36M | -10.68M | -466.00K | -10.10M | -69.35M |